Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | H5 | Mar 01, 2024 | ||||||
GSE249909 |
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade
|
1 |
|
Richard Tobin | Mar 01, 2024 | |||
GSE250365 |
PRDM3/16 Regulate Chromatin Accessibility Required for NKX2-1 Mediated Alveolar Epithelial Differentiations and Function [scRNA-seq]
|
4 | Yan Xu | Mar 01, 2024 | ||||
GSE250366 |
PRDM3/16 Regulate Chromatin Accessibility Required for NKX2-1 Mediated Alveolar Epithelial Differentiations and Function
|
46 |
|
Yan Xu | Mar 01, 2024 | |||
GSE252938 |
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or Menin inhibitor
|
34 | Xiaoping Su | Mar 01, 2024 | ||||
GSE254780 |
Formation of Memory Assemblies through the DNA Sensing Tlr9 Pathway
|
5 | Jelena Radulovic | Mar 01, 2024 | ||||
GSE255544 |
Single cell RNA sequencing and single cell TCR sequencing of Type 2 lymphocytes in human nasal polyps
|
8 | Patrick Brennan | Mar 01, 2024 | ||||
GSE252936 |
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or Menin inhibitor (scATAC-Seq)
|
6 | Xiaoping Su | Mar 01, 2024 |